Concepedia
Statistics
Publications
26
Citations
3.4K
H-Index
20
Active since
1980
Affiliations
Sanofi (France)(Current)
University of Cagliari
Sanofi (Italy)
Sanofi (Turkey)
Inserm
M. Arnone is an author at Sanofi (France) specializing in medicine, pharmacology, and life sciences.
Publications per year
1980–2016
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors
M. Arnone, Jeanne Maruani, Frédérique Chaperon et al. · Psychopharmacology · 1997 · 595 citations
Medicine, Neuroscience, Pharmacology +13
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
Christine Ravinet Trillou, Claire Delgorge, Christel Menet et al. · International Journal of Obesity · 2004 · 585 citations
Medicine, Endocrinology, Pharmacology +11
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
Christine Ravinet Trillou, M. Arnone, Claire Delgorge et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2003 · 564 citations
Medicine, Endocrinology, Pharmacology +17
The CB1 receptor antagonist rimonabant reverses the diet‐induced obesity phenotype through the regulation of lipolysis and energy balance
Omar Jbilo, Christine Ravinet‐Trillou, M. Arnone et al. · The FASEB Journal · 2005 · 345 citations
Life Sciences, Molecular Biology, Pharmacology +17
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats
Magali Gary‐Bobo, Ghizlane Elachouri, Jean François Gallas et al. · Hepatology · 2007 · 304 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
1–5 of 26